{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:42:30Z","timestamp":1780504950933,"version":"3.54.1"},"reference-count":106,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Adverse drug reactions (ADRs) are gradually becoming a concerning health threat worldwide in patients undergoing acute or chronic therapy. Antibiotics are the main drugs that cause immune-mediated ADRs, such as severe cutaneous adverse reactions (SCARs), allergic reactions, and organ-specific diseases, representing a significant threat to patient safety. In this review, we present the current genetic evidence available for antibiotic-related toxicities from a pharmacogenomics (PGx) perspective. We also explore the current state of PGx-based dosing recommendations and the factors limiting their widespread application in routine clinical practice. Through a systematic literature review, this study identified at least 12 antibiotic\u2013gene pairs (amikacin\u2013<jats:italic>MT-RNR1<\/jats:italic>, gentamicin\u2013<jats:italic>MT-RNR1<\/jats:italic>, kanamycin\u2013<jats:italic>MT-RNR1<\/jats:italic>, streptomycin\u2013<jats:italic>MT-RNR1<\/jats:italic>, neomycin\u2013<jats:italic>MT-RNR1<\/jats:italic>, tobramycin\u2013<jats:italic>MT-RNR1<\/jats:italic>, isoniazid\u2013<jats:italic>NAT2<\/jats:italic>, dapsone\u2013<jats:italic>HLA-B<\/jats:italic>, co-trimoxazole\u2013<jats:italic>HLA-B<\/jats:italic>, <jats:italic>HLA-C<\/jats:italic>, flucloxacillin\u2013<jats:italic>HLA-B<\/jats:italic>, daunorubicin\u2013<jats:italic>SLC28A3<\/jats:italic>, and doxorubicin\u2013<jats:italic>SLC28A3<\/jats:italic>) with moderate to high Pharmacogenomics Knowledgebase (PharmGKB) evidence levels for toxicity. However, PGx-based dosing guidelines, as recommended by the Clinical Pharmacogenetics Implementation Consortium (CPIC), the Dutch Pharmacogenetics Working Group (DPWG), and the Canadian Pharmacogenomics Network for Drug Safety (CPNDS), are currently available only for the following antibiotic\u2013gene pairs<jats:italic>:<\/jats:italic> amikacin, gentamicin, kanamycin, streptomycin<jats:italic>,<\/jats:italic> neomycin, and tobramycin\u2013<jats:italic>MT-RNR1<\/jats:italic>; flucloxacillin\u2013<jats:italic>HLA-B<\/jats:italic>; dapsone\u2013<jats:italic>G6PD<\/jats:italic>; nitrofurantoin\u2013<jats:italic>G6PD<\/jats:italic>; and daunorubicin and doxorubicin\u2013<jats:italic>RARG<\/jats:italic>, <jats:italic>SLC28A3<\/jats:italic>, and <jats:italic>UGT1A6<\/jats:italic>. Despite the established and growing genetic evidence for toxicity, particularly for Co-trimoxazole-induced SCARs by <jats:italic>HLA-B<\/jats:italic> and <jats:italic>HLA-C<\/jats:italic>, dapsone-induced SCARs by the <jats:italic>HLA-B<\/jats:italic>, and isoniazid-induced liver injury by the <jats:italic>NAT2<\/jats:italic>, insufficient approaches are being undertaken to translate these findings into routine clinical practice. The lack of validation of preliminary genetic associations, due to the scarcity of proper follow-up and large-scale replication, remains a key setback for PGx-based implementation of antibiotic therapy in clinical settings. More focused clinical studies, cost-effectiveness analyses, and polygenic risk score development are required to enable the PGx-based clinical use of antibiotics and optimize both safety and effectiveness in achieving precision medicine.<\/jats:p>","DOI":"10.3389\/fphar.2025.1651909","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:49:37Z","timestamp":1759297777000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacogenomics of antibiotic-induced hypersensitivity reactions: current evidence and implications in clinical practice"],"prefix":"10.3389","volume":"16","author":[{"given":"Mohitosh","family":"Biswas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murshadul Alam","family":"Murad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Ismail Hossain","family":"Ashik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maliheh","family":"Ershadian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonlaphat","family":"Sukasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000003457","article-title":"Clinical and HLA associations of fluoroquinolone-induced liver injury: results from the drug-induced liver injury network","author":"Ahmad","year":"2025","journal-title":"Am. J. Gastroenterol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"531","DOI":"10.2217\/pgs.09.6","article-title":"TNF, LTA, HSPA1L and HLA-DR gene polymorphisms in HIV-positive patients with hypersensitivity to cotrimoxazole","volume":"10","author":"Alfirevic","year":"2009","journal-title":"Pharmacogenomics"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3109\/10428194.2012.752080","article-title":"Pharmacogenetic analysis in the treatment of hodgkin lymphoma","volume":"54","author":"Alt\u00e9s","year":"2013","journal-title":"Leuk. Lymphoma"},{"key":"B4","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/bcp.13008","article-title":"Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity","volume":"82","author":"Aminkeng","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"23294860","DOI":"10.1101\/2023.08.30.23294860","article-title":"Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort","author":"Amorim","year":"2023"},{"key":"B6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1440-1681.2012.05713.x","article-title":"NAT2 and CYP2E1 polymorphisms associated with antituberculosis drug-induced hepatotoxicity in Chinese patients","volume":"39","author":"An","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaip.2023.09.011","article-title":"Vancomycin-induced liver injury, DRESS, and HLA-A\u221732:01","volume":"12","author":"Asif","year":"2024","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e20230338","DOI":"10.36416\/1806-3756\/e20230338","article-title":"Role of the IL8 rs4073 polymorphism in central nervous system toxicity in patients receiving multidrug-resistant tuberculosis treatment","volume":"50","author":"Badamasi","year":"2024","journal-title":"J. Bras. Pneumol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e1417","DOI":"10.1002\/wsbm.1417","article-title":"PharmGKB: a worldwide resource for pharmacogenomic information","volume":"10","author":"Barbarino","year":"2018","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/tpj.2016.26","article-title":"Risk factors of isoniazid-induced hepatotoxicity in Tunisian tuberculosis patients","volume":"17","author":"Ben Fredj","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1200\/jco.2011.34.8987","article-title":"Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the children's oncology group","volume":"30","author":"Blanco","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/s0140-6736(18)32218-9","article-title":"Antibiotic allergy","volume":"393","author":"Blumenthal","year":"2019","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1002\/cpt.1403","article-title":"The influence of pharmacogenetic variants in HIV\/tuberculosis coinfected patients in Uganda in the SOUTH study","volume":"106","author":"Calcagno","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e0186200","DOI":"10.1371\/journal.pone.0186200","article-title":"Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patients","volume":"12","author":"Chan","year":"2017","journal-title":"PLoS One"},{"key":"B15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10528-015-9683-z","article-title":"Relationship of MTHFR and NQO1 pharmacogenetics and chemotherapy clinical outcomes in breast cancer patients","volume":"53","author":"Chaturvedi","year":"2015","journal-title":"Biochem. Genet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1001\/archdermatol.2010.198","article-title":"Drug reaction with eosinophilia and systemic symptoms: a retrospective study of 60 cases","volume":"146","author":"Chen","year":"2010","journal-title":"Arch. Dermatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/jcpt.12211","article-title":"The association between HLA-DQB1 polymorphism and antituberculosis drug-induced liver injury: a case-control study","volume":"40","author":"Chen","year":"2015","journal-title":"J. Clin. Pharm. Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/apt.18160","article-title":"Clinical characteristics and HLA associations of azithromycin-induced liver injury","volume":"60","author":"Conlon","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/tpj.2015.24","article-title":"A non-synonymous polymorphism in galectin-3 lectin domain is associated with allergic reactions to beta-lactam antibiotics","volume":"16","author":"Cornejo-Garc\u00eda","year":"2016","journal-title":"Pharmacogenomics J."},{"key":"B20","unstructured":"Clinical pharmacogenetics implementation consortium\n          \n          \n          2025"},{"key":"B21","unstructured":"Canadian pharmacogenomics network for drug safety\n          \n          \n          2025"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1000667","DOI":"10.3389\/fgene.2022.1000667","article-title":"Polygenic risk scores: an overview from bench to bedside for personalised medicine","volume":"13","author":"Cross","year":"2022","journal-title":"Front. Genet."},{"key":"B23","article-title":"Gentamicin therapy and MT-RNR1 genotype","author":"Dean","year":"2018"},{"key":"B24","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1046\/j.1365-2222.1997.540848.x","article-title":"Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes","volume":"27","author":"Dekker","year":"1997","journal-title":"Clin. Exp. Allergy"},{"key":"B25","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1002\/hep.23805","article-title":"Antituberculosis therapy drug-induced liver injury and acute liver failure","volume":"52","author":"Devarbhavi","year":"2010","journal-title":"Hepatology"},{"key":"B26","first-page":"363","article-title":"Drug hypersensitivity reactions: response patterns, drug involved, and temporal variations in a large series of patients","volume":"22","author":"Do\u00f1a","year":"2012","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"B27","unstructured":"The Dutch guidelines November 2018 update"},{"key":"B28","unstructured":"Dutch pharmacogenetics working group"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1016\/s0140-6736(16)30378-6","article-title":"Severe cutaneous adverse reactions to drugs","volume":"390","author":"Duong","year":"2017","journal-title":"Lancet"},{"key":"B30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1080\/00498254.2024.2330493","article-title":"Effects of pharmacogenetics on pharmacokinetics and toxicity of doxorubicin in Egyptian breast cancer patients","volume":"54","author":"Ebaid","year":"2024","journal-title":"Xenobiotica"},{"key":"B31","doi-asserted-by":"publisher","first-page":"3525","DOI":"10.1093\/hmg\/ddp295","article-title":"Harnessing the information contained within genome-wide association studies to improve individual prediction of complex disease risk","volume":"18","author":"Evans","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"B32","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jaad.2011.12.014","article-title":"Toxic epidermal necrolysis: five years of treatment experience from a burn unit","volume":"67","author":"Firoz","year":"2012","journal-title":"J. Am. Acad. Dermatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/s0196-0709(97)90078-8","article-title":"Mitochondrial gene mutation is a significant predisposing factor in aminoglycoside ototoxicity","volume":"18","author":"Fischel-Ghodsian","year":"1997","journal-title":"Am. J. Otolaryngol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/cpt.2735","article-title":"Expanded clinical pharmacogenetics implementation consortium guideline for medication use in the context of G6PD genotype","volume":"113","author":"Gammal","year":"2023","journal-title":"Clin. Pharmacol. Ther."},{"key":"B35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41397-022-00266-8","article-title":"HLA-B*07:02 and HLA-C*07:02 are associated with trimethoprim-sulfamethoxazole respiratory failure","volume":"22","author":"Goldman","year":"2022","journal-title":"Pharmacogenomics J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/1471-2431-14-210","article-title":"Mitochondrial mutation m.1555A>G as a risk factor for failed newborn hearing screening in a large cohort of preterm infants","volume":"14","author":"G\u00f6pel","year":"2014","journal-title":"BMC Pediatr."},{"key":"B37","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/sj.tpj.6500456","article-title":"Association of tumor necrosis factor-alpha -308G>A polymorphism with IgE-mediated allergy to betalactams in an Italian population","volume":"8","author":"Gu\u00e9ant-Rodriguez","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"B38","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/s1665-2681(19)31302-x","article-title":"Association of GST null genotypes with anti-tuberculosis drug induced hepatotoxicity in Western Indian population","volume":"12","author":"Gupta","year":"2013","journal-title":"Ann. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"171","DOI":"10.35460\/2546-1621.2017-0031","article-title":"Epidemiology of severe cutaneous adverse drug reactions in a university hospital: a five-year review","volume":"2","author":"Guzman","year":"2018","journal-title":"J. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/cpt.924","article-title":"Antituberculosis drug-induced adverse events in the liver, kidneys, and blood: clinical profiles and pharmacogenetic predictors","volume":"104","author":"Hu","year":"2018","journal-title":"Clin. Pharmacol. Ther."},{"key":"B41","doi-asserted-by":"publisher","first-page":"693.e1","DOI":"10.1016\/j.jaad.2013.01.033","article-title":"DRESS syndrome: part I. Clinical perspectives","volume":"68","author":"Husain","year":"2013","journal-title":"J. Am. Acad. Dermatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"107391","DOI":"10.1016\/j.isci.2023.107391","article-title":"An association study of HLA with levofloxacin-induced severe cutaneous adverse drug reactions in han Chinese","volume":"26","author":"Jiang","year":"2023","journal-title":"iScience"},{"key":"B43","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.jaci.2003.12.591","article-title":"Revised nomenclature for allergy for global use: report of the nomenclature review committee of the world allergy organization, October 2003","volume":"113","author":"Johansson","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.jaip.2020.09.011","article-title":"A nationwide study of severe cutaneous adverse reactions based on the multicenter registry in Korea","volume":"9","author":"Kang","year":"2021","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B45","doi-asserted-by":"publisher","first-page":"107895","DOI":"10.1016\/j.ijid.2025.107895","article-title":"One-year mortality of tuberculosis patients on isoniazid-based treatment and its association with rapid acetylator NAT2 genotypes","volume":"155","author":"Kasamatsu","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1080\/13696998.2023.2270868","article-title":"Cost-effectiveness analysis of HLA-B*13:01 screening for the prevention of co-trimoxazole-induced severe cutaneous adverse reactions among HIV-Infected patients in Thailand","volume":"26","author":"Kategeaw","year":"2023","journal-title":"J. Med. Econ."},{"key":"B47","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1478-3231.2011.02697.x","article-title":"TNF\u2010\u03b1 genetic polymorphism\u2212 308G\/A and antituberculosis drug\u2010induced hepatitis","volume":"32","author":"Kim","year":"2012","journal-title":"Liver Int."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/ph14111077","article-title":"A comprehensive review of HLA and severe cutaneous adverse drug reactions: implication for clinical pharmacogenomics and precision medicine","volume":"14","author":"Kloypan","year":"2021","journal-title":"Pharm. (Basel)"},{"key":"B49","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jaci.2019.01.045","article-title":"HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms","volume":"144","author":"Konvinse","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.ajhg.2020.08.008","article-title":"Genome-wide study identifies association between HLA-B(\u2217)55:01 and self-reported penicillin allergy","volume":"107","author":"Krebs","year":"2020","journal-title":"Am. J. Hum. Genet."},{"key":"B51","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fphar.2019.00206","article-title":"Association study among candidate genetic polymorphisms and chemotherapy-related severe toxicity in testicular cancer patients","volume":"10","author":"Lavanderos","year":"2019","journal-title":"Front. Pharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1080\/14622416.2024.2346069","article-title":"Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity","volume":"25","author":"Lee","year":"2024","journal-title":"Pharmacogenomics"},{"key":"B53","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1017\/s0266462319000321","article-title":"Health technology assessment in Thailand: institutionalization and contribution to healthcare decision making: review of literature","volume":"35","author":"Leelahavarong","year":"2019","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"B54","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3892\/mmr.2012.900","article-title":"SLCO1B1 *15 haplotype is associated with rifampin-induced liver injury","volume":"6","author":"Li","year":"2012","journal-title":"Mol. Med. Rep."},{"key":"B55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.tube.2018.05.011","article-title":"rs1800796 of the IL6 gene is associated with increased risk for anti-tuberculosis drug-induced hepatotoxicity in Chinese Han children","volume":"111","author":"Li","year":"2018","journal-title":"Tuberc. (Edinb)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1136\/hrt.2007.136093","article-title":"Anthracycline associated cardiotoxicity in survivors of childhood cancer","volume":"94","author":"Lipshultz","year":"2008","journal-title":"Heart"},{"key":"B57","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.mito.2010.01.007","article-title":"Mitochondrial 12S rRNA variants in 1642 han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss","volume":"10","author":"Lu","year":"2010","journal-title":"Mitochondrion"},{"key":"B58","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1002\/cpt.2309","article-title":"Clinical pharmacogenetics implementation consortium guideline for the use of aminoglycosides based on MT-RNR1 genotype","volume":"111","author":"Mcdermott","year":"2022","journal-title":"Clin. Pharmacol. Ther."},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000335612","article-title":"Epidemiology of cutaneous adverse drug reactions","volume":"97","author":"Mockenhaupt","year":"2012","journal-title":"Chem. Immunol. Allergy"},{"key":"B60","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1365-2710.2012.01368.x","article-title":"The roles of GSTM1 and GSTT1 null genotypes and other predictors in anti-tuberculosis drug-induced liver injury","volume":"37","author":"Monteiro","year":"2012","journal-title":"J. Clin. Pharm. Ther."},{"key":"B61","doi-asserted-by":"publisher","first-page":"100480","DOI":"10.1016\/j.dmpk.2022.100480","article-title":"Associations of HLA and drug-metabolizing enzyme genes in co-trimoxazole-induced severe cutaneous adverse reactions","volume":"47","author":"Nakkam","year":"2022","journal-title":"Drug Metab. Pharmacokinet."},{"key":"B62","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/cpt.1375","article-title":"Drug-induced liver injury due to flucloxacillin: relevance of multiple human leukocyte antigen alleles","volume":"106","author":"Nicoletti","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jaci.2020.10.004","article-title":"Beta-lactam-induced immediate hypersensitivity reactions: a genome-wide association study of a deeply phenotyped cohort","volume":"147","author":"Nicoletti","year":"","journal-title":"J. Allergy Clin. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/cpt.2100","article-title":"Genetic risk factors in drug-induced liver injury due to isoniazid-containing antituberculosis drug regimens","volume":"109","author":"Nicoletti","year":"","journal-title":"Clin. Pharmacol. Ther."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1111\/bcp.15659","article-title":"Cardiotoxicity and pharmacogenetics of doxorubicin in black Zimbabwean breast cancer patients","volume":"90","author":"Nyangwara","year":"2024","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/bs.apha.2018.03.002","article-title":"Pharmacogenetics of adverse drug reactions","volume":"83","author":"Osanlou","year":"2018","journal-title":"Adv. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.mcna.2021.04.001","article-title":"Recognition and management of severe cutaneous adverse drug reactions (including drug reaction with eosinophilia and systemic symptoms, Stevens-Johnson syndrome, and toxic epidermal necrolysis)","volume":"105","author":"Owen","year":"2021","journal-title":"Med. Clin. North Am."},{"key":"B69","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"Bmj"},{"key":"B70","doi-asserted-by":"publisher","first-page":"100901","DOI":"10.1016\/j.waojou.2024.100901","article-title":"HLA-DRB1 is associated with cefaclor-induced immediate hypersensitivity","volume":"17","author":"Park","year":"2024","journal-title":"World Allergy Organ J."},{"key":"B71","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.jaip.2017.01.025","article-title":"Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice","volume":"5","author":"Peter","year":"2017","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"B72","unstructured":"Clinical annotation levels of evidence"},{"key":"B73","unstructured":"Drug label information and legend"},{"key":"B74","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jceh.2012.12.001","article-title":"Hepatotoxicity related to anti-tuberculosis drugs: mechanisms and management","volume":"3","author":"Ramappa","year":"2013","journal-title":"J. Clin. Exp. Hepatol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e27681","DOI":"10.1002\/pbc.27681","article-title":"No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy","volume":"66","author":"Robinson","year":"2019","journal-title":"Pediatr. Blood Cancer"},{"key":"B76","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3233\/ves-2008-18106","article-title":"Susceptibility genes for gentamicin-induced vestibular dysfunction","volume":"18","author":"Roth","year":"2008","journal-title":"J. Vestib. Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens-Johnson syndrome and toxic epidermal necrolysis: comparison with case-control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"B78","doi-asserted-by":"publisher","first-page":"661135","DOI":"10.3389\/fimmu.2021.661135","article-title":"HLA-B*13:01 is a predictive marker of dapsone-induced severe cutaneous adverse reactions in Thai patients","volume":"12","author":"Satapornpong","year":"2021","journal-title":"Front. Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.3390\/ijms26083881","article-title":"NAT2 acetylation status predicts hepatotoxicity during antituberculosis therapy: cumulative risk analysis of a multiethnic cohort","volume":"26","author":"Schiuma","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR study","volume":"58","author":"Schneck","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1002\/cpt.1915","article-title":"Genetic association of co-trimoxazole-induced severe cutaneous adverse reactions is phenotype-specific: HLA class I genotypes and haplotypes","volume":"108","author":"Sukasem","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e02692-18","DOI":"10.1128\/aac.02692-18","article-title":"Genomewide association study confirming the association of NAT2 with susceptibility to antituberculosis drug-induced liver injury in Thai patients","volume":"63","author":"Suvichapanich","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B83","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/fpc.0000000000000306","article-title":"Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population","volume":"27","author":"Tempark","year":"2017","journal-title":"Pharmacogenet Genomics"},{"key":"B84","doi-asserted-by":"publisher","first-page":"832048","DOI":"10.3389\/fphar.2022.832048","article-title":"Drug-induced severe cutaneous adverse reactions: insights into clinical presentation, immunopathogenesis, diagnostic methods, treatment, and pharmacogenomics","volume":"13","author":"Tempark","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2478316","DOI":"10.1080\/07853890.2025.2478316","article-title":"Pharmacogenomic heterogeneity of N-acetyltransferase 2: a comprehensive analysis of real world data in Indian tuberculosis patients and from literature and database review","volume":"57","author":"Thomas","year":"2025","journal-title":"Ann. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00280-020-04177-y","article-title":"Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy","volume":"87","author":"Tsuji","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jhep.2017.03.010","article-title":"Minocycline hepatotoxicity: clinical characterization and identification of HLA-B\u221735:02 as a risk factor","volume":"67","author":"Urban","year":"2017","journal-title":"J. Hepatol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.mjafi.2013.01.007","article-title":"Severe cutaneous adverse drug reactions","volume":"69","author":"Verma","year":"2013","journal-title":"Med. J. Armed Forces India"},{"key":"B89","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1200\/jco.2010.34.3467","article-title":"Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children","volume":"30","author":"Visscher","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1002\/pbc.24505","article-title":"Validation of variants in SLC28A3 and UGT1A6 as genetic markers predictive of anthracycline-induced cardiotoxicity in children","volume":"60","author":"Visscher","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2217\/pgs.15.61","article-title":"Genetic variants in SLC22A17 and SLC22A7 are associated with anthracycline-induced cardiotoxicity in children","volume":"16","author":"Visscher","year":"2015","journal-title":"Pharmacogenomics"},{"key":"B92","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s00228-006-0111-5","article-title":"CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis","volume":"62","author":"Vuilleumier","year":"2006","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"B93","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1755-8794-5-32","article-title":"Polymorphism in glutamate cysteine ligase catalytic subunit (GCLC) is associated with sulfamethoxazole-induced hypersensitivity in HIV\/AIDS patients","volume":"5","author":"Wang","year":"2012","journal-title":"BMC Med. Genomics"},{"key":"B94","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/iji.12678","article-title":"Polymorphisms of HLA genes and hypersensitivity to penicillin among patients in a Taiwanese population","volume":"51","author":"Wang","year":"","journal-title":"Int. J. Immunogenet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"17167","DOI":"10.1038\/s41598-024-68185-1","article-title":"Association of HLA alleles with cephalosporin allergy in the Taiwanese population","volume":"14","author":"Wang","year":"","journal-title":"Sci. Rep."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.5588\/ijtld.15.0310","article-title":"NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients","volume":"20","author":"Wattanapokayakit","year":"2016","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/cpt.2350","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo","year":"2021","journal-title":"Clin. Pharmacol. Ther."},{"key":"B98","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/tpj.2010.5","article-title":"Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity","volume":"10","author":"Yamada","year":"2010","journal-title":"Pharmacogenomics J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.2217\/pgs.14.69","article-title":"HLA-B*13:01 is associated with salazosulfapyridine-induced drug rash with eosinophilia and systemic symptoms in Chinese Han population","volume":"15","author":"Yang","year":"2014","journal-title":"Pharmacogenomics"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e0165933","DOI":"10.1371\/journal.pone.0165933","article-title":"Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis: a nationwide population-based study using national health insurance database in Korea","volume":"11","author":"Yang","year":"2016","journal-title":"PLoS One"},{"key":"B101","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/tpj.2016.61","article-title":"HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions","volume":"17","author":"Yang","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"B102","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/tpj.2013.32","article-title":"Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG phase III trial S0221 for breast cancer","volume":"14","author":"Yao","year":"2014","journal-title":"Pharmacogenomics J."},{"key":"B103","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/jhg.2016.10","article-title":"NAT2 variants are associated with drug-induced liver injury caused by anti-tuberculosis drugs in Indonesian patients with tuberculosis","volume":"61","author":"Yuliwulandari","year":"2016","journal-title":"J. Hum. Genet."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2217\/pgs-2019-0131","article-title":"NAT2 slow acetylator is associated with anti-tuberculosis drug-induced liver injury severity in indonesian population","volume":"20","author":"Yuliwulandari","year":"2019","journal-title":"Pharmacogenomics"},{"key":"B105","doi-asserted-by":"publisher","first-page":"481","DOI":"10.2174\/138920007780866780","article-title":"GSTP1 and MTHFR polymorphisms are related with toxicity in breast cancer adjuvant anthracycline-based treatment","volume":"8","author":"Z\u00e1rate","year":"2007","journal-title":"Curr. Drug Metab."},{"key":"B106","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1111\/jcpt.13097","article-title":"The role of NAT2 polymorphism and methylation in anti-tuberculosis drug-induced liver injury in Mongolian tuberculosis patients","volume":"45","author":"Zhang","year":"2020","journal-title":"J. Clin. Pharm. Ther."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1651909\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:49:41Z","timestamp":1759297781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1651909\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":106,"alternative-id":["10.3389\/fphar.2025.1651909"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1651909","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"article-number":"1651909"}}